Back to rounds

Company profile

Breye Therapeutics

Breye Therapeutics, a biopharmaceutical firm that provide cutting-edge oral treatments for the management of retinal vascular diseases.

Location
Hørsholm, Hovedstaden, Denmark, Europe
Website
breyetx.com

Latest known funding

Series A round

Capital
$76.7M
Announced
Sep 29, 2026